No Result
View All Result
  • Login
Saturday, August 15, 2026
theadvisertimes.com
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
No Result
View All Result
theadvisertimes.com
No Result
View All Result
Home Markets

The $4,200 Ozempic Ransom You Have to Pay Every Year to Keep the Weight Off

by theadvisertimes.com
7 months ago
in Markets
Reading Time: 3 mins read
A A
0
The ,200 Ozempic Ransom You Have to Pay Every Year to Keep the Weight Off
Share on FacebookShare on TwitterShare on LInkedIn


It feels like the weight-loss miracle so many have been waiting for. You watch the transformation videos on TikTok, see the celebrities shrinking before your eyes and hear the stories of friends who have effortlessly dropped 30 pounds.

Ozempic (semaglutide) has become the “Kleenex” of diet culture — a catch-all name for a weekly injection that melts fat without the misery of starvation.

But there’s a major catch. These drugs are not a cure. They are a treatment. Like blood pressure medication, they only work as long as you take them.

And there’s one crucial question every potential user should ask before their first dose: What happens when I stop?

The science of the rebound

Clinical trials paint a sobering picture for both major drug types.

For Ozempic and Wegovy (semaglutide) users, research found that one year after stopping the drug, participants regained two-thirds of their lost weight.

For Zepbound (tirzepatide) users, the news is similar. In a study of the drug, all participants took tirzepatide for 36 weeks and lost significant weight. Researchers then switched a randomized portion of the group to a placebo, at which point they regained 14% of their body weight in the following year, effectively erasing the majority of their progress.

It’s a matter of biology. When you lose weight rapidly, your body fights to get it back. It lowers your metabolism and ramps up your hunger hormones.

These drugs work by suppressing those signals. When you remove the drug, the dam breaks. Your body doesn’t just go back to normal. It often swings hard in the other direction to recover lost fat storage.

The return of ‘food noise’

One of the most praised effects of these drugs is the silencing of “food noise” — that constant mental chatter about what to eat next. For many users, this is the first time in their lives they haven’t felt obsessed with food.

When they stop the medication, that noise comes back, often louder than before.

Obesity specialists have noted that patients don’t just feel hungry; they feel an intense, biological drive to eat that can be overwhelming.

Because they haven’t necessarily built the psychological habits or muscle mass to maintain the weight naturally (since the drug did the heavy lifting), they’re left defenseless against these cravings.

The financial reality of a forever prescription

If you’re taking these drugs for weight loss, you need to budget for them like you would a utility bill.

As of early 2026, the pricing has shifted. While retail prices without insurance still hover near $1,000 per month, manufacturers have introduced new cash-pay options (like Zepbound vials or Wegovy intro offers) that can drop the price to the $199 to $399 range for eligible patients.

However, even at $350 a month, you’re looking at roughly $4,200 a year — indefinitely.

If you rely on insurance, remember that coverage is fickle. Medicare is starting to shift its rules regarding weight loss drugs, but there’s no guarantee of coverage. Other insurance coverage varies.

If you change jobs, lose coverage or your insurer changes their formulary, you could be forced to stop cold turkey and face the risk of regaining weight.

The health whiplash

Beyond the number on the scale, stopping these medications can shock your system.

Blood sugar spikes: If you were using these drugs for Type 2 diabetes or even pre-diabetes, stopping can cause your blood glucose levels to surge. This is dangerous and requires immediate management by a doctor.
Cardiometabolic regression: The clinical trials also found that improvements in cardiometabolic risk factors (like blood pressure and inflammation markers) reverted to baseline once the weight came back. You lose the heart health protection along with the weight.

Is it worth it?

This doesn’t mean you shouldn’t take them. For people with severe obesity or diabetes, these drugs are lifesavers. But you need to shift your mindset.

Don’t view Zepbound or Ozempic as a jumpstart to get skinny for a wedding or a reunion. Think of it instead as a lifetime management tool for a chronic condition.

If you aren’t willing — or financially able — to take it for the long haul, you might be setting yourself up for an expensive, heartbreaking cycle of yo-yo dieting that leaves you heavier than when you started.



Source link

Tags: OzempicPayransomweightyear
ShareTweetShare
Previous Post

ZOOZ provides Israelis with exposure to Bitcoin

Next Post

Where Prediction Markets Fit in Portfolios

Related Posts

Is Lettuce Safe to Eat Now? What to Know Amid Cyclospora Outbreak

Is Lettuce Safe to Eat Now? What to Know Amid Cyclospora Outbreak

by theadvisertimes.com
August 8, 2026
0

An unprecedented outbreak of cyclosporiasis, a lettuce-linked parasitic infection known to cause debilitating diarrhea, has sickened more Americans than ever...

All signs are pointing to the total and imminent collapse of the United States housing market.

All signs are pointing to the total and imminent collapse of the United States housing market.

by theadvisertimes.com
August 7, 2026
0

All signs are pointing to the total and imminent collapse of the United States housing market.What is about to happen...

nLIGHT Releases Q2 2026 Financial Results

nLIGHT Releases Q2 2026 Financial Results

by theadvisertimes.com
August 7, 2026
0

AlphaStreet Newsdesk powered by AlphaStreet Intelligence LASR|EPS $0.15 vs $0.14 est (+7.1%)|Rev $82.6M|Net Loss $1.3M Q2 2026 non-GAAP earnings at...

The  Burrito Debate Reveals GOP’s Affordability Rift

The $20 Burrito Debate Reveals GOP’s Affordability Rift

by theadvisertimes.com
August 7, 2026
0

Sometimes a burrito isn’t just a burrito. What started as a complaint about a $20 burrito has turned into one...

Johnson Outdoors Delivers Strong Q3 2026 Results, Revenue Up 5%

Johnson Outdoors Delivers Strong Q3 2026 Results, Revenue Up 5%

by theadvisertimes.com
August 7, 2026
0

AlphaStreet Newsdesk powered by AlphaStreet Intelligence JOUT|EPS $1.42 vs $0.68 est (+108.8%)|Rev $189.7M vs $186.2M est (+1.9%)|Net Income $14.9M Stock...

AI Is Starting to Improve Itself

AI Is Starting to Improve Itself

by theadvisertimes.com
August 7, 2026
0

This week, we’ve explored two of the biggest questions surrounding artificial intelligence. First, just how close are we to artificial...

Next Post
Where Prediction Markets Fit in Portfolios

Where Prediction Markets Fit in Portfolios

Stephen Miller vs ICE Barbie & Corey Is a Distraction From Civil Conflict

Stephen Miller vs ICE Barbie & Corey Is a Distraction From Civil Conflict

  • Trending
  • Comments
  • Latest
SEC pushes private market access, but retail is already in

SEC pushes private market access, but retail is already in

July 16, 2026
The Weekly Notable Startup Funding Report: 6/22/26 – AlleyWatch

The Weekly Notable Startup Funding Report: 6/22/26 – AlleyWatch

June 21, 2026
Biggerpockets Pro Members Can Now Turn Home Equity Into a Flexible Line of Credit With Aven

Biggerpockets Pro Members Can Now Turn Home Equity Into a Flexible Line of Credit With Aven

August 3, 2026
The Weekly Notable Startup Funding Report: 7/20/26 – AlleyWatch

The Weekly Notable Startup Funding Report: 7/20/26 – AlleyWatch

July 20, 2026
The 19 Largest Global Startup Funding Rounds of June 2026 – AlleyWatch

The 19 Largest Global Startup Funding Rounds of June 2026 – AlleyWatch

July 27, 2026
Managed accounts ramping up tax alpha services: Cerulli

Managed accounts ramping up tax alpha services: Cerulli

July 20, 2026
XRP Price Forecast as Binance Whale Activity Remains Elevated Amid XRPL Tokenization Push

XRP Price Forecast as Binance Whale Activity Remains Elevated Amid XRPL Tokenization Push

0
Wealth management has got junior advisors’ first 90 days covered. What happens on day 91?

Wealth management has got junior advisors’ first 90 days covered. What happens on day 91?

0
Is Lettuce Safe to Eat Now? What to Know Amid Cyclospora Outbreak

Is Lettuce Safe to Eat Now? What to Know Amid Cyclospora Outbreak

0
The Unwinnable Iran War | Armstrong Economics

The Unwinnable Iran War | Armstrong Economics

0
Bezeq declares NIS 515m dividend

Bezeq declares NIS 515m dividend

0
AI Will Clarify What Asset Managers Are Paid For

AI Will Clarify What Asset Managers Are Paid For

0
XRP Price Forecast as Binance Whale Activity Remains Elevated Amid XRPL Tokenization Push

XRP Price Forecast as Binance Whale Activity Remains Elevated Amid XRPL Tokenization Push

August 8, 2026
Is Lettuce Safe to Eat Now? What to Know Amid Cyclospora Outbreak

Is Lettuce Safe to Eat Now? What to Know Amid Cyclospora Outbreak

August 8, 2026
Bitcoin outlook: ,000 or ,000 this weekend

Bitcoin outlook: $70,000 or $60,000 this weekend

August 8, 2026
Mortgage and refinance interest rates today, Saturday, August 8, 2026: Rates mixed this weekend

Mortgage and refinance interest rates today, Saturday, August 8, 2026: Rates mixed this weekend

August 8, 2026
CEO of the world’s largest workspace provider says commuting will be extinct by 2040

CEO of the world’s largest workspace provider says commuting will be extinct by 2040

August 8, 2026
F&O Talk: Smallcaps look strong on charts, says Sudeep Shah; outlines Trent, Swiggy, Kalyan Jewellers strategy

F&O Talk: Smallcaps look strong on charts, says Sudeep Shah; outlines Trent, Swiggy, Kalyan Jewellers strategy

August 8, 2026
theadvisertimes.com

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Financial Planning
  • Investing
  • Market Analysis
  • Markets
  • Money
  • Personal Finance
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • XRP Price Forecast as Binance Whale Activity Remains Elevated Amid XRPL Tokenization Push
  • Is Lettuce Safe to Eat Now? What to Know Amid Cyclospora Outbreak
  • Bitcoin outlook: $70,000 or $60,000 this weekend
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • About Us
  • Contact Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.